Daniel Navarini1,2,3,4, Carlos Augusto S Madalosso5,6,7,8, Alexandre P Tognon2, Fernando Fornari2,3, Fábio R Barão3, Richard R Gurski4. 1. Gastrobese Clinic, Passo Fundo, RS, Brazil. 2. Hospital São Vicente de Paulo, Passo Fundo, RS, Brazil. 3. Universidade de Passo Fundo, Passo Fundo, RS, Brazil. 4. Programa de Pós-Graduação: Ciências Cirúrgicas, Faculdade de Medicina, Departamento de Cirurgia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. 5. Gastrobese Clinic, Passo Fundo, RS, Brazil. gbbariatrica@gmail.com. 6. Hospital São Vicente de Paulo, Passo Fundo, RS, Brazil. gbbariatrica@gmail.com. 7. Universidade de Passo Fundo, Passo Fundo, RS, Brazil. gbbariatrica@gmail.com. 8. Gastrobese Clinic, Rua Uruguai 1953, 8° andar, Passo Fundo, RS, CEP 99010112, Brazil. gbbariatrica@gmail.com.
Abstract
OBJECTIVE: To evaluate the impact of laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB) on gastroesophageal reflux disease (GERD) in patients with obesity. METHODS:Patients with class II or III obesity were treated with LSG or LRYGB. Procedure choice was based on patients and surgeon preferences. GERD symptoms, endoscopy, barium swallow X-ray, esophageal manometry, and 24-h pH monitoring were obtained before and 1 year after surgery. RESULTS:Seventy-five patients underwent surgery (83% female, 39.3 ± 12.1 years, BMI of 41.5 ± 5.1 kg/m2): 35 (46.7%) had LSG and 40 (53.3%) LRYGB. LSG patients had lower BMI (40.3 ± 4.0 kg/m2 vs. 42.7 ± 5.7 kg/m2; p = 0.041) and trend toward lower prevalence of GERD (20% vs. 40%; p = 0.061). One year after surgeries, GERD was more frequent in LSG patients (74% vs. 25%; p < 0.001) and all LSG patients with preoperative GERD continue to have GERD postoperatively. De novo GERD occurred in 19 of 28 (67.9%) of LSG patients and 4 of 24 (16.7%) patients treated with LRYGB (OR 10.6, 95%CI 2.78-40.1). Independent predictors for post-operative GERD were as follows: LSG (OR 12.3, 95%CI 2.9-52.5), preoperative esophagitis (OR 8.5, 95% CI 1.6-44.8), and age (OR 2.0, 95%CI 1.1-3.4). CONCLUSIONS: One year after surgery, persistent or de novo GERD were substantially more frequent in patients treated with LSG compared with LRYGB. LSG was the strongest predictor for GERD in our trial. Preoperative counseling and choice of bariatric surgical options must include a detailed assessment and discussion of GERD-related surgical outcomes.
RCT Entities:
OBJECTIVE: To evaluate the impact of laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (LRYGB) on gastroesophageal reflux disease (GERD) in patients with obesity. METHODS:Patients with class II or III obesity were treated with LSG or LRYGB. Procedure choice was based on patients and surgeon preferences. GERD symptoms, endoscopy, barium swallow X-ray, esophageal manometry, and 24-h pH monitoring were obtained before and 1 year after surgery. RESULTS: Seventy-five patients underwent surgery (83% female, 39.3 ± 12.1 years, BMI of 41.5 ± 5.1 kg/m2): 35 (46.7%) had LSG and 40 (53.3%) LRYGB. LSG patients had lower BMI (40.3 ± 4.0 kg/m2 vs. 42.7 ± 5.7 kg/m2; p = 0.041) and trend toward lower prevalence of GERD (20% vs. 40%; p = 0.061). One year after surgeries, GERD was more frequent in LSG patients (74% vs. 25%; p < 0.001) and all LSG patients with preoperative GERD continue to have GERD postoperatively. De novo GERD occurred in 19 of 28 (67.9%) of LSG patients and 4 of 24 (16.7%) patients treated with LRYGB (OR 10.6, 95%CI 2.78-40.1). Independent predictors for post-operative GERD were as follows: LSG (OR 12.3, 95%CI 2.9-52.5), preoperative esophagitis (OR 8.5, 95% CI 1.6-44.8), and age (OR 2.0, 95%CI 1.1-3.4). CONCLUSIONS: One year after surgery, persistent or de novo GERD were substantially more frequent in patients treated with LSG compared with LRYGB. LSG was the strongest predictor for GERD in our trial. Preoperative counseling and choice of bariatric surgical options must include a detailed assessment and discussion of GERD-related surgical outcomes.
Authors: Ronit T Yehoshua; Leonid A Eidelman; Michael Stein; Suzana Fichman; Amir Mazor; Jacopo Chen; Hanna Bernstine; Pierre Singer; Ram Dickman; Nahum Beglaibter; Scott A Shikora; Raul J Rosenthal; Moshe Rubin Journal: Obes Surg Date: 2008-06-06 Impact factor: 4.129
Authors: Ramiro Gálvez-Valdovinos; José Luis Cruz-Vigo; Ernesto Marín-Santillán; Juan Francisco Funes-Rodríguez; Gustavo López-Ambriz; Luis Gerardo Domínguez-Carrillo Journal: Obes Surg Date: 2015-08 Impact factor: 4.129
Authors: Fernando Fornari; Antônio Carlos Gruber; Antônio de Barros Lopes; Dileta Cecchetti; Sérgio Gabriel Silva de Barros Journal: Arq Gastroenterol Date: 2005-03-29
Authors: Carlos Augusto S Madalosso; Richard Ricachenevsky Gurski; Sidia M Callegari-Jacques; Daniel Navarini; Guilherme Mazzini; Marina da Silva Pereira Journal: Ann Surg Date: 2016-01 Impact factor: 12.969
Authors: Ayman El Nakeeb; Hassan Aldossary; Ahmed Zaid; Mohamed El Sorogy; Mohamad Elrefai; Mohamed Attia; Alaa Mostafa Sewefy; Taha Kayed; Mubarak Al-Shari Aldawsari; Hathal Mashan Al Dossari; Mohammed M Mohammed Journal: Obes Surg Date: 2022-09-10 Impact factor: 3.479
Authors: Raul Sebastian; Omar M Ghanem; Jorge Cornejo; Thomas Ruttger; Matthew Mayuiers; Gina Adrales; Christina Li Journal: Surg Endosc Date: 2022-01-12 Impact factor: 3.453